Area of research
Immunology · Virology
Research interest
Research interests include HIV Research and Treatment, Immune Cell Function and Interaction, T-cell and B-cell Immunology, and Immunotherapy and Immune Responses.
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans
Vaccination with an mRNA-encoded membrane-bound HIV envelope trimer induces neutralizing antibodies in animal models
HIV broadly neutralizing antibody precursors to the Apex epitope induced in nonhuman primates
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Structural basis of a shared antibody response to SARS-CoV-2
Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses
Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan
Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles
An MPER antibody neutralizes HIV-1 using germline features shared among donors
The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen
HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage
CXCL13 is a plasma biomarker of germinal center activity
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability
Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch
Human Circulating PD-1+CXCR3−CXCR5+ Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses